M. Maestro

发表

Value of serum neuron-specific enolase in nonsmall cell lung cancer.

J. Balibrea, A. Gómez, A. Torres, 1993, Oncology.

Circulating tumoral cells lack circadian-rhythm in hospitalized metastasic breast cancer patients

M. Sanz-Casla, J. García-Saenz, Miguel Martín, 2006, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

External Quality Assurance of Circulating Tumor Cell Enumeration Using

S. Sleijfer, T. Fehm, J. Foekens, 2011 .

External quality assurance of circulating tumor cell enumeration using the CellSearch® system: A feasibility study

S. Sleijfer, T. Fehm, J. Foekens, 2011, Cytometry. Part B, Clinical cytometry.

Quantitative analysis of carcinoembryonic antigen, squamous cell carcinoma antigen, CA 125, and CA 50 cytosolic content in non‐small cell lung cancer

J. Balibrea, A. Torres, A. Picardo, 1994, Cancer.

Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer.

C. Pericay, C. Grávalos, E. Díaz-Rubio, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Telomerase activity in colorectal cancer, prognostic factor and implications in the microsatellite instability pathway.

M. Sanz-Casla, J. Cerdán, M. Vidaurreta, 2007, World journal of gastroenterology.

Diagnostic and predictive value of urine PCA3 gene expression for the clinical management of patients with altered prostate-specific antigen

X. Puig, I. Trias, J. M. Banús, 2014 .

Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study.

J. Tabernero, A. Abad, B. Massuti, 2012, The oncologist.

Serum CEA, CA125, and SCC antigens and tumor recurrence in resectable non-small cell lung cancer

J. Balibrea, A. Gómez, A. Torres, 1995, The International journal of biological markers.

Analysis of the prognostic significance of cytosolic determination of CA 125 tumor‐associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma

J. Balibrea, A. Gómez, A. Torres, 1996 .

Prognostic value of the quantified expression of p185 in non-small cell lung cancer.

C. Fernández, J. Balibrea, A. Gómez, 2000, The Journal of thoracic and cardiovascular surgery.

Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables.

M. Sanz-Casla, J. García-Saenz, E. Díaz-Rubio, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic significance of the p185 protein in colorectal cancer.

M. Sanz-Casla, C. Fernández, J. Balibrea, 2004, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Tissue Quantification of CA 125 in Epithelial Ovarian Cancer

J. Vidart, E. Iglesias, M. Maestro, 1999, The International journal of biological markers.

Influence of A9 Region Mutation in EphB2 Gene in the Prognosis of Patients with Colorectal Adenocarcinoma

J. Cerdán, C. Fernández, M. Vidaurreta, 2011, Annals of Surgical Oncology.

Cuesta

M. Maestro, J. A. Vidart, E. Iglesias, 2021, Encyclopedic Dictionary of Archaeology.

Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis

S. Sleijfer, L. Esserman, B. Naume, 2018, Journal of the National Cancer Institute.

Role of the BRAF Mutations in the Microsatellite Instability Genetic Pathway in Sporadic Colorectal Cancer

M. Sanz-Casla, J. Cerdán, M. Herranz, 2007, Annals of Surgical Oncology.

p16 Gene Methylation in Colorectal Tumors: Correlation with Clinicopathological Features and Prognostic Value

M. Sanz-Casla, J. Cerdán, M. Vidaurreta, 2005, Digestive Diseases.